🇨🇦 F-18 florbetapir PET in Canada

F-18 florbetapir PET (F-18 florbetapir PET) regulatory status in Canada.

Marketing authorisation

F-18 florbetapir PET in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is F-18 florbetapir PET approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for F-18 florbetapir PET in Canada?

Brigham and Women's Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.